FAU Blocking Peptide – The purity is >90%,tested by HPLC and MS. Purity

Name: FAU Blocking Peptide; The purity is >90%,tested by HPLC and MS. Purity; MyBioSource
Brand: MyBioSource
SKU: MBS9621707
Price: 460 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9621707

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the… More details

$460 / 1 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

FAU, Blocking Peptide

Full Product Name

FAU Blocking Peptide

Product Gene Name

FAU blocking peptide

Form/Format

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.

Purity/Purification

The purity is >90%,tested by HPLC and MS.

Preparation and Storage

Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C.

Antibody/Peptide Pairs

FAU peptide (MBS9621707) is used for blocking the activity of FAU antibody (MBS9611754)

Molecular Weight

6,648 Da

OMIM

134690

Supply Chain Verification

Manufactured in a lab with traceable raw materials manufactured on site. Coordinated product portfolio of antibodies, pairs, conjugates, recombinant proteins, and immunoassay materials available, please inquire.

Notes

For phospho antibody, we provide phospho peptide (0.5mg) and non-phospho peptide (0.5mg)

ISO Certification

Manufactured in an ISO 9001:2015 Certified Laboratory.

Applications Tested/Suitable for FAU blocking peptide

Blocking/Control

Other Notes

Small volumes of FAU blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for FAU purchase

MBS9621707 is a blocking peptide targeting FAU.

Additional Details

NCBI/Uniprot data below describe general gene information for FAU. It may not necessarily be applicable to this product.

NCBI GI #

51338655

NCBI GeneID

2197

NCBI Accession #

P62861.1

UniProt Primary Accession #

P62861

UniProt Secondary Accession #

Q05472; Q95261; Q9H5V4

UniProt Related Accession #

P35544; P62861

NCBI Official Full Name

40S ribosomal protein S30

NCBI Official Synonym Full Names

Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed

NCBI Official Symbol

FAU

NCBI Official Synonym Symbols

S30; FAU1; Fub1; Fubi; asr1; RPS30; MNSFbeta

UniProt Protein Name

40S ribosomal protein S30

Protein Family

40S ribosomal protein

UniProt Gene Name

FAU

UniProt Entry Name

RS30_HUMAN

NCBI Protein Information

ubiquitin-like protein fubi and ribosomal protein S30

NCBI Summary for FAU

This gene is the cellular homolog of the fox sequence in the Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV). It encodes a fusion protein consisting of the ubiquitin-like protein fubi at the N terminus and ribosomal protein S30 at the C terminus. It has been proposed that the fusion protein is post-translationally processed to generate free fubi and free ribosomal protein S30. Fubi is a member of the ubiquitin family, and ribosomal protein S30 belongs to the S30E family of ribosomal proteins. Whereas the function of fubi is currently unknown, ribosomal protein S30 is a component of the 40S subunit of the cytoplasmic ribosome and displays antimicrobial activity. Pseudogenes derived from this gene are present in the genome. Similar to ribosomal protein S30, ribosomal proteins S27a and L40 are synthesized as fusion proteins with ubiquitin. [provided by RefSeq, Nov 2014]

UniProt Comments for FAU

RPS30: This gene is the cellular homolog of the fox sequence in the Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV). It encodes a fusion protein consisting of the ubiquitin-like protein fubi at the N terminus and ribosomal protein S30 at the C terminus. It has been proposed that the fusion protein is post-translationally processed to generate free fubi and free ribosomal protein S30. Fubi is a member of the ubiquitin family, and ribosomal protein S30 belongs to the S30E family of ribosomal proteins. Whereas the function of fubi is currently unknown, ribosomal protein S30 is a component of the 40S subunit of the cytoplasmic ribosome. Pseudogenes derived from this gene are present in the genome. Similar to ribosomal protein S30, ribosomal proteins S27a and L40 are synthesized as fusion proteins with ubiquitin. [provided by RefSeq, Jul 2008]

Protein type: Apoptosis; Translation; Ribosomal

Chromosomal Location of Human Ortholog: 11q13

Cellular Component: cytosol; extracellular space; small ribosomal subunit

Molecular Function: RNA binding; structural constituent of ribosome

Biological Process: antibacterial humoral response; cellular protein metabolic process; defense response to Gram-positive bacterium; gene expression; innate immune response in mucosa; mRNA catabolic process, nonsense-mediated decay; selenium metabolic process; selenocysteine metabolic process; SRP-dependent cotranslational protein targeting to membrane; translation; translational elongation; translational initiation; translational termination; viral infectious cycle; viral reproduction; viral transcription

Research Articles on FAU

1. The C-terminal portion of the encoded protein displays antimicrobial activity against B. megaterium.

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Pathways associated with FAU blocking peptide

Products by Pathway	Pathway Diagram
Activation Of The MRNA Upon Binding Of The Cap-binding Complex And EIFs, And Subsequent Binding To 43S Pathway antibodies	Activation Of The MRNA Upon Binding Of The Cap-binding Complex And EIFs, And Subsequent Binding To 43S Pathway Diagram
Cap-dependent Translation Initiation Pathway antibodies	Cap-dependent Translation Initiation Pathway Diagram
Cytoplasmic Ribosomal Proteins Pathway antibodies	Cytoplasmic Ribosomal Proteins Pathway Diagram
Disease Pathway antibodies	Disease Pathway Diagram
Eukaryotic Translation Elongation Pathway antibodies	Eukaryotic Translation Elongation Pathway Diagram
Eukaryotic Translation Initiation Pathway antibodies	Eukaryotic Translation Initiation Pathway Diagram
Eukaryotic Translation Termination Pathway antibodies	Eukaryotic Translation Termination Pathway Diagram
Formation Of A Pool Of Free 40S Subunits Pathway antibodies	Formation Of A Pool Of Free 40S Subunits Pathway Diagram
Formation Of The Ternary Complex, And Subsequently, The 43S Complex Pathway antibodies	Formation Of The Ternary Complex, And Subsequently, The 43S Complex Pathway Diagram
GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway antibodies	GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway Diagram

Organs/Tissues associated with FAU blocking peptide

Organ/Tissue Name	Pubmed Publications
Brain Antibodies	>249 publications with FAU and Brain
Blood Antibodies	>184 publications with FAU and Blood
Heart Antibodies	>75 publications with FAU and Heart
Muscle Antibodies	>67 publications with FAU and Muscle
Liver Antibodies	>61 publications with FAU and Liver
Vascular Antibodies	>57 publications with FAU and Vascular
Bone Antibodies	>56 publications with FAU and Bone
Eye Antibodies	>53 publications with FAU and Eye
Nerve Antibodies	>51 publications with FAU and Nerve
Kidney Antibodies	>46 publications with FAU and Kidney